Imres continues to be eligible supplier to USAID and GHSC-PSM

During the month of November, 2020, USAID (GHSC-QA) has audited Imres BV as part of the regular audit schedule to re-certify procurement agencies and wholesalers.
Based on the exceptionally positive outcome, Imres has been informed that we continue to be fully compliant with WHO TRS 986, annex 3 MQAS, thereby renewing its eligibility status to USAID and GHSC-PSM.
We are proud but humble to continue partnering with USAID-funded organizations to support our mission: providing access to quality controlled and cost-effective medicines, medical products and solutions to people with unmet needs in low- and middle-income countries.